Oncology Molecular Diagnostic Market Size To Grow USD 7.71 Billion by 2033

According to a recent research report titled “Oncology Molecular Diagnostic Market (By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer; By Technology: PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others; By Product: Instruments, Reagents, Others ) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033″ published by Precedence Research, the global oncology molecular diagnostic market size is projected to touch around USD 7.71 billion by 20323 and growing at a CAGR of 12.20% over the forecast period 2023 to 2033. This comprehensive study examines various factors and their impact on the growth of the oncology molecular diagnostic market.

Key Takeaways

• North America contributed more than 41% of the market share in 2023.
• Asia-Pacific is estimated to expand the fastest CAGR between 2024 and 2033.
• By type, the breast cancer segment generated over 22% of the market share in 2023.
• By type, the liver cancer segment is anticipated to grow at a remarkable CAGR of 13.9% between 2024 and 2033.
• By technology, the polymerase chain reaction (PCR) segment generated over 32% of the market share in 2023.
• By technology, the sequencing segment is expected to expand at the fastest CAGR over the projected period.
• By product, the reagents segment generated over 59% of market share in 2023.
• By product, the instruments segment is expected to expand at the fastest CAGR over the projected period.

The report primarily focuses on the volume and value of the oncology molecular diagnostic market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3677

The research also highlights significant progressions in both organic and inorganic growth strategies within the global oncology molecular diagnostic market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the oncology molecular diagnostic market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Oncology Molecular Diagnostic Market  Scope

Also read: Nickel Market Size To Cross USD 78.47 Billion By 2033

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the oncology molecular diagnostic market.

Oncology Molecular Diagnostic Market Companies

• Roche Diagnostics
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Genomic Health, Inc.
• Myriad Genetics, Inc.
• Agilent Technologies, Inc.
• Siemens Healthineers
• Danaher Corporation (Cepheid)
• Sysmex Corporation
• Hologic, Inc.
• Guardant Health, Inc.
• Foundation Medicine, Inc.

Segments Covered in the Report:

By Type

• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Cervical Cancer
• Liver Cancer
• Lung Cancer
• Blood Cancer
• Kidney Cancer
• Other Cancer

By Technology

• PCR
• In Situ Hybridization
• INAAT
• Chips and Microarrays
• Mass Spectrometry
• Sequencing
• TMA
• Others

By Product

• Instruments
• Reagents
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Content:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oncology Molecular Diagnostic Market 

5.1. COVID-19 Landscape: Oncology Molecular Diagnostic Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oncology Molecular Diagnostic Market, By Type

8.1. Oncology Molecular Diagnostic Market Revenue and Volume, by Type, 2024-2033

8.1.1 Breast Cancer

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Prostate Cancer

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Colorectal Cancer

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Cervical Cancer

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Liver Cancer

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Lung Cancer

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Lung Cancer

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Blood Cancer

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

8.1.9. Kidney Cancer

8.1.9.1. Market Revenue and Volume Forecast (2021-2033)

8.1.10. Other Cancer

8.1.10.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Oncology Molecular Diagnostic Market, By February

9.1. Oncology Molecular Diagnostic Market Revenue and Volume, by February, 2024-2033

9.1.1. Cathode

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Anode

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Electrolyte

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Separator

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Oncology Molecular Diagnostic Market, By March 

10.1. Oncology Molecular Diagnostic Market Revenue and Volume, by March, 2024-2033

10.1.1. Consumer

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Automotive

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Industrial

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Cheese

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Oncology Molecular Diagnostic Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by March (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by February (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by March (2021-2033)

Chapter 12. Company Profiles

12.1. Roche Diagnostics

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott Laboratories

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Thermo Fisher Scientific Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Illumina, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Qiagen N.V.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Bio-Rad Laboratories, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genomic Health, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Myriad Genetics, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Agilent Technologies, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Siemens Healthineers

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global oncology molecular diagnostic market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for oncology molecular diagnostic. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Oncology molecular diagnostic market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Oncology molecular diagnostic market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Oncology molecular diagnostic market?
• What is the Oncology molecular diagnostic market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Oncology molecular diagnostic market?
• What are the recent trends in Oncology molecular diagnostic market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Oncology molecular diagnostic market growth?
• What are the key market trends impacting the growth of Oncology molecular diagnostic market?

 

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---